These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 15077588

  • 1. [Skeletal involvement in Hodgkin's lymphoma--personal experience].
    Feltl D, Marková J, Kozák T.
    Vnitr Lek; 2004 Feb; 50(2):134-8. PubMed ID: 15077588
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of bone involvement in Hodgkin lymphoma.
    Feltl D, Markova J, Mocikova H, Dedeckova K, Kozak T.
    Neoplasma; 2008 Feb; 55(2):96-100. PubMed ID: 18237246
    [Abstract] [Full Text] [Related]

  • 3. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A.
    J Clin Oncol; 2007 May 20; 25(15):2000-5. PubMed ID: 17420510
    [Abstract] [Full Text] [Related]

  • 4. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
    Barbieri E, Cammelli S, Mauro F, Perini F, Cazzola A, Neri S, Bunkheila F, Ferrari S, Brandoli V, Zinzani P, Mercuri M, Bacci G.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):760-4. PubMed ID: 15183479
    [Abstract] [Full Text] [Related]

  • 5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 01; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb 01; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 7. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I.
    Bone Marrow Transplant; 2007 Oct 01; 40(7):651-8. PubMed ID: 17660837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Mounier N, Gisselbrecht C, Brière J, Haioun C, Feugier P, Offner F, Recher C, Stamatoullas A, Morschhauser F, Macro M, Thieblemont C, Sonet A, Fabiani B, Reyes F, Groupe d'Etude des Lymphomes de l'Adulte.
    J Clin Oncol; 2004 Jul 15; 22(14):2826-34. PubMed ID: 15254050
    [Abstract] [Full Text] [Related]

  • 11. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
    Rodríguez J, Conde E, Gutiérrez A, Arranz R, Gandarillas M, Leon A, Ojanguren J, Sureda A, Carrera D, Bendandi M, Moraleda J, Ribera JM, Albo C, Morales A, García JC, Fernández P, Cañigral G, Bergua J, Caballero MD, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea.
    Eur J Haematol; 2007 Apr 15; 78(4):290-6. PubMed ID: 17378891
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S, Divine CL, Deauna-Limayo D, Bodensteiner DC, Cook JD, Lewis JN, Skikne BS.
    Ann Hematol; 2005 Aug 15; 84(8):526-31. PubMed ID: 15915350
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):208-18. PubMed ID: 15093918
    [Abstract] [Full Text] [Related]

  • 15. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
    Rueffer U, Sieber M, Stemberg M, Gossmann A, Josting A, Koch T, Grotenhermen F, Diehl V, German Hodgkin's Lymphoma Study Group (GHSG).
    Ann Hematol; 2003 Jul 01; 82(7):390-6. PubMed ID: 12764547
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A, Haverkamp H, Engert A, Balleisen L, Majunke P, Heil G, Eich HT, Stein H, Diehl V, Josting A.
    J Clin Oncol; 2005 Aug 20; 23(24):5739-45. PubMed ID: 16009944
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, Klapper W, Wacker HH, Ludwig WD, Niggli F, Mann G, Gadner H, Riehm H, Schrappe M, Reiter A.
    J Clin Oncol; 2007 Sep 01; 25(25):3915-22. PubMed ID: 17761975
    [Abstract] [Full Text] [Related]

  • 18. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
    Nogová L, Reineke T, Brillant C, Sieniawski M, Rüdiger T, Josting A, Bredenfeld H, Skripnitchenko R, Müller RP, Müller-Hermelink HK, Diehl V, Engert A, German Hodgkin Study Group.
    J Clin Oncol; 2008 Jan 20; 26(3):434-9. PubMed ID: 18086799
    [Abstract] [Full Text] [Related]

  • 19. High-dose chemotherapy and autologous stem cell transplantation for Hodgkin's lymphoma in the kingdom of Saudi Arabia: King Faisal specialist hospital and research center experience.
    Akhtar S, Abdelsalam M, El Weshi A, Al Husseini H, Janabi I, Rahal M, Maghfoor I.
    Bone Marrow Transplant; 2008 Aug 20; 42 Suppl 1():S37-S40. PubMed ID: 18724297
    [Abstract] [Full Text] [Related]

  • 20. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F, Zengin N, Engin H, Güllü I, Barista I, Caglar M, Ozyar E, Cengiz M, Gürkaynak M, Zorlu F, Caner B, Atahan IL, Tekuzman G.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):839-46. PubMed ID: 15465201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.